SCHEMBL6176672

SCHEMBL6176672

COc1cc(Oc2csc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.37
BLM P54132 1/20 0.37
MAPT P10636 3/20 0.37
KDM4E B2RXH2 2/20 0.37
PRMT6 Q96LA8 1/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PTGER1 P34995 1/20 0.32
IDH1 O75874 2/20 0.32
IDH2 P48735 1/20 0.32
SCN9A Q15858 1/20 0.32
PDE10A Q9Y233 1/20 0.32
ALPL P05186 2/20 0.31
ALPI P09923 2/20 0.31
THRB P10828 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176976 0.86 PRMT6 (0.34) L3MBTL1BLMKDM4EPRMT6IDH1
SCHEMBL6178748 0.83 KDM4E (0.38) KDM4EPRMT6IDH1SCN9ALMNA
SCHEMBL6181367 0.77 PRMT6 (0.38) MAPTPRMT6IDH1IDH2SCN9A
SCHEMBL6177302 0.74 PRMT6 (0.39) BLMMAPTKDM4EPRMT6MEN1
SCHEMBL8124547 0.73 MAOB (0.40) L3MBTL1BLMMAPTKDM4EALDH1A1
SCHEMBL8120425 0.72 MAPT (0.47) L3MBTL1MAPTKDM4EKMT2AALDH1A1
SCHEMBL8111632 0.72 EIF4E (0.39) L3MBTL1BLMMAPTKDM4EMEN1
SCHEMBL6178955 0.72 PRMT6 (0.34) PRMT6IDH1IDH2SCN9A
SCHEMBL6723685 0.72 PRMT6 (0.37) MAPTPRMT6GABRA1GABRG2GABRB3
SCHEMBL6182022 0.72 PRMT6 (0.37) MAPTPRMT6PTGER1IDH1IDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1427725-B1 PYRAZOLYL-SUBSTITUTED THIENYLOXYPYRIDINES BASF AG (DE) 2005-03-23 EP disclosed
US-20040235667-A1 Pyrazolyl-substituted thienyloxypyridines BASF AKTIENGESELLSCHAFT (DE) 2004-11-25 US disclosed
EP-1427725-A1 PYRAZOLYL-SUBSTITUTED THIENYLOXYPYRIDINES BASF AKTIENGESELLSCHAFT (DE) 2004-06-16 EP disclosed
WO-2003022843-A1 PYRAZOLYL-SUBSTITUTED THIENYLOXYPYRIDINES BASF AKTIENGESELLSCHAFT (DE) 2003-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235667-A1 Pyrazolyl-substituted thienyloxypyridines HDHD5, CBR3, KCNH3 L3MBTL1 820/4885BLM 4036/4885MAPT 4682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.